Filing Details

Accession Number:
0000849146-23-000153
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-26 16:06:40
Reporting Period:
2023-09-22
Accepted Time:
2023-09-26 16:06:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
849146 Lifevantage Corp LFVN Pharmaceutical Preparations (2834) 900224471
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1698767 Darwin Lewis 3300 Triumph Blvd, Suite 700
Lehi UT 84043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-22 4,124 $6.94 89,408 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected by an automatic purchase pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.77 to $6.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.